title: Cellular adoptive immunotherapy after allogeneic stem cell transplantation.
abstract: OBJECTIVE
  This review presents the role of donor lymphocyte infusion, natural killer cells, and dendritic cells in cellular immunotherapy after allogeneic stem cell transplantation.
  
  
  RESULTS
  It becomes increasingly possible to infuse more specialized subsets of lymphocyte cells after transplantation. The infusion of natural killer cells, especially in non human leukocyte antigen-identical transplantation, may become an important tool in enhancing the graft-versus-tumor effect. Vaccination of patients after stem cell transplantation with autologous-derived dendritic cells merits further investigation.
  
  
  CONCLUSIONS
  Stem cell transplantation has evolved to a specialized form of immunotherapy.
authors.affiliation: Department of Hematology and Central Hematology Laboratory, Radboud University Nijmegen Medical Centre, The Netherlands. a.schattenberg@hemat.umcn.nl
authors.forename: Anton V M B
authors.initials: AV
authors.lastname: Schattenberg
authors.forename: Harry
authors.initials: H
authors.lastname: Dolstra
mesh_terms: D003713:Dendritic Cells / Q000276:immunology; D006086:Graft vs Host Disease / Q000209:etiology; D020544:Graft vs Leukemia Effect / Q000502:physiology*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D016219:Immunotherapy, Adoptive; D007694:Killer Cells, Natural / Q000276:immunology; D009369:Neoplasms / Q000628:therapy*